February 2026: BD (Becton, Dickinson and Company), a leading global medical technology company, is accelerating the future of healthcare delivery through its comprehensive Connected Care strategy, an integrated ecosystem designed to enhance clinical outcomes, improve operational efficiency, and enable predictive, precision-based care across healthcare environments.
At the core of BD’s Connected Care approach are three strategic pillars that together form a seamless and intelligent care continuum.
The first pillar, Pharmacy Automation, encompasses advanced solutions such as automated pill packaging, single-dose medication preparation, and robotic storage optimization. These technologies are deployed across retail, hospital, and central fill pharmacies to improve accuracy, efficiency, and medication safety while reducing the burden on healthcare professionals.
The second pillar focuses on Medication Management Solutions, led by the globally recognized Alaris infusion platform, where BD is among the leading companies globally. The platform enhances medication delivery accuracy and safety, helping clinicians administer treatments with greater confidence and control.
The third pillar, Advanced Patient Monitoring, builds on capabilities recently acquired from Edwards Lifesciences and centres on haemodynamic monitoring and cardiac insights. Through non-invasive, minimally invasive, and invasive technologies, BD enables clinicians to gain deeper visibility into a patient’s cardiovascular status, supporting timely and informed interventions.
Also read:Dubai Health Insurance Coverage Exceeds 4.9 Million Beneficiaries in 2025, DHA Reports
Advancing connected care through technology and AI
“BD’s vision extends beyond optimising standalone systems. The company is building an integrated system layer that connects data across devices and care settings. By enabling AI-driven predictive analytics and advanced hypotension monitoring tools, BD aims to shift healthcare from reactive to proactive care models,” said Bilal Muhsin Executive Vice President and President of the Connected Care Segment at BD.
Through this integration, clinicians can anticipate patient deterioration before it becomes critical rather than responding after complications arise. BD’s unique position, combining expertise in both medication delivery and real-time patient monitoring, allows the development of a closed-loop system that continuously informs clinicians about treatment effectiveness. This integrated intelligence supports more precise, data-driven clinical decision-making and enhances overall care quality.
Driving measurable clinical outcomes
BD Connected Care is designed to deliver tangible improvements in healthcare performance and patient wellbeing. The company’s primary objectives include reducing hospital length of stay, lowering ICU and hospital readmissions, and improving overall patient outcomes.
“By integrating actionable data insights with clinical decision support tools, BD empowers healthcare providers to deliver proactive, precision-based care tailored to individual patient needs. The result is improved safety, greater efficiency, and more sustainable healthcare systems,” added Bilal.
Extending care beyond hospital walls
As healthcare increasingly shifts toward home care and lower-acuity settings, BD is expanding its Connected Care framework beyond traditional hospital environments. The company is developing a continuous, cloud-based, AI-enabled platform capable of supporting monitoring and treatment across diverse care settings.
“This approach ensures continuity of care regardless of location, enabling patients to receive consistent, high-quality monitoring and support whether they are in hospital, at home, or in outpatient facilities,” concluded Bilal.
Through its Connected Care strategy, BD is redefining how healthcare systems connect technology, data, and clinical expertise, advancing a more predictive, integrated, and patient-centred future of care.
